Transgenic mice in the study of ALS: The role of neurofilaments

Brain Pathology

Volumn 8, Issue 4, 1998, Pages 759-769

  Julien, Jean Pierre ^a   Couillard Després, Sébastien ^a   Meier, Jurgen ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; GENE MUTATION; GENE OVEREXPRESSION; MOTOR NEUROPATHY; MOUSE; NEUROFILAMENT; NEUROPATHOLOGY; NONHUMAN; TRANSGENIC MOUSE;

EID: 0031683605     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.1998.tb00199.x     Document Type: Conference Paper

References (88)

1. Anderson PM, Nilsson P, Ala-Hurula V, Keranen ML, Tarvainen I, Haltia T, Nilsson L, Binzer M, Forsgren L, Marklund SL (1995) Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in Cu/Zn superoxide dismutase. Nature Genet 10: 61-66
2. Beckman JS, Carson M, Smith CD, Koppenol, WH (1993) ALS, SOD and peroxynitrite. Nature 364: 584
3. Bergeron C, Beric-Maskarel K, Muntasser S, Weyer L, Somerville MJ, Percy ME (1994) Neurofilament Light and Polyadenylated mRNA Levels Are Decreased in Amyotrophic Lateral Sclerosis Motor Neurons. J Neuropathol Exp Neurol 53: 221-230
4. Borchelt DR, Lee MK, Slunt HS, Guarnieri M, Xu ZS, Wong PC, Brown RH Price DL, Sisodia SS, Cleveland DW (1994) Superoxyde dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc Nat. Acad Sci USA 91: 8292-8296
5. Brimijioin S (1984) The role of axonal transport in nerve disease. In Dyk, P.J., Thomas P.K., Lambert E.H., Bunge R. eds. Peripheral Neuropathy, Vol. 1, Philadelphia: W.B. Sunders Company., 477-493
6. Brown RH (1995) Amyotrophic lateral sclerosis: Recent insights from genetics and transgenic mice. Cell 80: 687-692
7. Bruijn LI, Beal MF, Becher MW, Schulz JB, Wong PC, Price, DL, Cleveland DW (1997) Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant. Proc Natl Acad Sci USA 94: 7606-7611
8. Bruijn LI, Becher MW, Lee MK, Anderson KL, Jenkins NA, Copeland NG, Sisodia SS, Rothstein JD, Borchelt DR, Price DL, Cleveland DW (1997) ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18, 327-338
9. Carpenter S (1968) Proximal enlargement in motor neuron diseases. Neurology 18: 841-851
10. Ching G, Liem R (1993) Assembly of type IV neuronal intermediate filaments in nonneuronal cells in the absence of preexisting cytoplasmic intermediate filaments. Cell Biol 122: 1323-1335
11. Chou SM, Wang HS, Koma IK (1996) Colocalization of NOS and SOD1 in neurofilament accumulation within motor neurons of amyotrophic lateral sclerosis: an immunohistochemical study. J Chem Neuroanat 10: 249-258
12. Cleveland DW (1996) Neuronal growth and death: order and disorder in the axoplasm. Cell 84: 663-666
13. Cohlberg JA, Hajarian H, Tran T, Alipourjeddi P, Noveen A (1995) Neurofilament protein heterotetramers as assembly intermediates. J Bio Chem 270: 9334-9339
14. Collard JF, Côté F, Julien JP (1995) Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature 375: 61-64
15. Côté F, Collard JF, Julien JP (1993) Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: A mouse model of amyotrophic lateral sclerosis. Cell 73: 35-46
16. Crapper McLachlan DR, Lukiw WJ, Wong L, Bergeron C, Bech-Hansen NT (1988) SelectivernessengerRNA reduction in Alzheimer's disease. Molec Brain Res 3: 255-262
17. Crow JP, Ye YZ, Strong M, Kirk M, Barnes S, Beckman JS (1997) Superoxide dismutase catalyzes nitration of tyrosines by peroxynitrite in the rod and head domains of neurofilament-L. J Neurochem 69: 1945-1953
18. Dal Canto MC, Gurney ME (1994) The development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am J Pathol 145: 1271-1279
19. de Belleroche J, Orrell, RW, Virgo L (1996) Amyotrophic lateral sclerosis:recent advances in understanding disease mechanisms. J Neuropathol Exp Neurol 55: 747-757
20. Elliott JL, Snider WD (1995) Parvalbumin is a marker of ALS-resistant motor neurons. Neuroreport 6: 442-452
21. Eyer J, Cleveland DW, Wong PC, Peterson AC (1998) Pathogenesis of two axonopathies does not require axonal neurofilaments. Nature 391: 584-587
22. Eyer J, Peterson A (1994) Neurofilament-deficient axons and perikaryal aggregates in viable transgenic mice expressing a neurofilament - galactosidase fusion protein. Neuron 12: 389-405
23. Ferrante RJ, Browne SE, Shinobu LA, Bowling AC, Baik MJ, Macgarvey U, Kowall NW, Brown RH, Beal MF (1997) Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem 69: 2064-2074
24. Figlewicz DA, Knzus A, Martinoli MG, Meininger V, Dib M, Rouleau GA, Julien JP (1994) Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum Mol Genet 3: 1757-1761
25. Figlewicz DA, Rouleau GA, Krizus A, Julien JP (1993) Polymorphism in the multi- phosphorylation domain of the human neurofilament heavy-subunit-encoding gene. Gene 132: 297-300
26. Fuchs E (1994) Intermediate filaments and disease: mutations that cripple cell strength. J Cell Biol 125: 511-516
27. Ghadge GD, Lee JP, Bindokas VP, Jordan J, Ma L, Miller RJ, Roos RP (1997) Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: molecular mechanisms of neuronal death and protection. J Neuroscience 15: 8756-8766
28. Gurney ME, Pu H, Chiu AY, Canto MCD, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX, Chen W, Zhai P, Sufit RL, Siddique T (1994) Motor neuron degeneration in mice expressing a human Cu Zn superoxide dismutase mutation. Science 264: 1772-1775
29. Gurney ME, Cutting FB, Zhai P, Andrus PK, Hall ED (1996) Pathogenic mechanisms in familial amyotrophic lateral sclerosis due to mutation of Cu, Zn superoxide dismutase. Pathologie Biologie 44: 51-56
30. Hill WD, Arai M, Cohen JA, Trojanowski, JO (1993) Neurofilament mRNA is Reduced in Parkinson's Disease Substantia Nigra Pars Compacta Neurons. J Comp Neurol 329: 328-336
31. Hirano A, Donnenfeld H, Sasaki S, Nakano I (1984) Fine structural observations of neurofilamentous changes in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 43: 461-470
32. Hirokawa N (1991) Molecular architecture and dynamics of the neuronal cyloskeleton. in R. D. Burgoyne, Ed., The Neuronal Cytoskeleton. Wiley-Liss incorporated, New York, 5-74.
33. Hisanaga S, Hirokawa N (1990) Molecular architecture of neurofilament: in vitro reassembly process of neurofilament-L protein. J Mol Biol 211: 871-882
34. Ho BK, Alexianu ME, Colom LV, Mohamed AH, Serrano F, Appel SH (1996) Expression of calbindin-D28K in motoneuron hybrid cells after retroviral infection with calbindin-D28K cDNA prevents amyotrophic lateral sclerosis IgG-mediated cytotoxicity. Proc Natl Acad Sci USA 93: 6796-6801
35. Hoffman PN, Lasek RJ (1975) The slow component of axonal transport, identification of the major structural polypeptides of the axon and their generality among mammalian neurons J Cell Biol 66: 351-366
36. Julien JP (1997) Neurofilaments and motor neuron disease. Trends Cell Biol 7: 243-249
37. Julien JP, Cote F, Beaudet L, Sidky M, Flavell D, Grosveld F, Mushynski WE (1988) Sequence and structure of the mouse gene coding for the largest neurofilament subunit. Gene 68: 307-314
38. Julien, JP, Tretjakoff I, Beaudet L, Peterson A (1987) Expression and assembly of a human neurofilament protein in transgenic mice provide a novel neuronal marking system. Genes Dev 1: 1085-1095
39. Klymkowsky MW, Plummer DJ (1985) Giant axonal neuropathy: A conditional Mutation Affecting Cytoskeletal Organization. J Cell Biol 100: 245-250
40. Krieger C, Jones K, Kim SU, Eisen AA (1994) The role of intracellular free calcium in motor neuron disease. J Neurol Sciences 124: 27-32
41. Krieger C, Lanius RA, Pelech SL, Shaw CA (1996) Amyotrophic lateral sclerosis: the involvement of intracellular calcium and protein kinase C. Trends Pharmacol Sci 17: 114-120
42. Kuchel GA, Poon T, Irshad K, Richard C, Julien JP, Cowen T (1997). Decreased neurofilament gene expression is an index of selective axonal hypotrophy in ageing. Neuroreport 8: 799-805
43. Lanius RA, Paddon HB, Mezei M, Wagey R, Krieger C, Pelech SL, Shaw CA (1995) A role for amplified protein kinase C activity in the pathogenesis of ALS. J Neurochem 65: 927-930
44. Lee MK, Marszlek JR, Cleveland DW (1994) A Mutant Neurofilament Subunit Causes Massive, Selective Motor Neuron Death: Implication for the Pathogenesis of Human Motor Neuron Disease. Neuron 13: 975-988
45. Lee MK, Xu Z, Wong PC, Cleveland DW (1993). Neurofilaments Are Obligate Heteropolymers In Vivo. J Cell Biol 122: 1337-1350
46. Lees JF, Shneidman PS, Skuntz SF, Carden MJ, Lazzarini RA (1988) The structure and organization of the human heavy neurofilament subunit (NF-H) and the gene encoding it. EMBO J 7: 1947-1955
47. Lefebvre S, Mushynski WE (1987) Calcium binding to untreated and dephosphorylated porcine neurofilaments. Biochem Biophys Res Commun 145: 1006-1011
48. Lefebvre S, Mushynski WE (1988) Characterization of the cation-binding properties of porcine neurofilaments. Biochemistry 27: 8503-8508
49. Leigh PN, Meldrum BS (1996) Excitotoxicity in ALS. Neurology 47: 221-227
50. Ma D, Descarries L, Julien JP, Doucet G (1995) Abnormal penkaryal accumulation of neurofilament light protein in the brain of mice transgenic for the human protein: sequence of postnatal development. Neuroscience 68: 135-149
51. Marszalek JR, Williamson TL, Lee MK, Xu Z, Hoffman PN, Crawford TO, Cleveland DW (1996) Neurofilament subunit NF-H modulates axonal diameter by selectively slowing neurofilament transport. J Cell Biol 135, 711-724
52. Miyasaka H, Okabe S, Ishiguro K, Uchida T, Hirokawa N (1993) Interaction of the tail domain of high molecular weight subunits of neurofilaments with the COOH-terminal region of tubulin and its regulation by tau protein kinase II. J Biol Chem 268: 22695-22702
53. Morrison BM, Gordon JW, Ripps ME, Morrison JH (1996) Quantitative immunocytochemical analysis of the spinal cord in G86R superoxide dismutase transgenic mice: neurochemical correlates of selective vulnerability. J Comp Neurol 373: 619-631
54. Mourelatos Z, Gonatas NK, Stieber A, Gurney ME, Dal Canto MC (1996) The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu,Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease. Proc Natl Acad Sci USA 93: 5472-5477
55. Nixon RA (1991) Axonal Transport of Cytoskeletal Proteins in R. D. Burgoyne, Ed., The Neuronal Cytoskeleton. Wiley-Liss, inc., 283-307
56. Nixon RA, Lewis SE, Mercken M, Sihag RK (1994) [32P]Orthophosphate and [35S]Methionine Label Separate Pools of Neurofilaments with Markedly Different Axonal Transport Kinetics in Mouse Retinal Ganglion Cells In Vivo. Neurochem Res 19: 1325-1333
57. Parhad IM, Scott JN, Cellars LA, Bains JS, Krekoski CA, Clark AW (1995) Axonal atrophy in aging is associated with a decline in neurofilament gene expression. J Neurosci Res 41-355-366
58. Pramatarova A, Goto J, Eiji N, Nakashima K, Takahashi K, Takagi A, Kanazawa I, Figlewicz DA, Rouleau GA (1994) A two basepair deletion in the SOD1 gene causes familail amyotrophic lateral sclerosis. Hum Mol Genet 3: 2061-2062
59. Reaume AG, Elliott JL, Hoffman EK, Kowall NW, Ferrante RJ, Siwek DF, Wilcox HM, Flood DG, Beal MF, Brown RH, Scott RW, Snider WD (1996) Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nature Genet 13: 43-47
60. Reiner A, Medina L, Figueredo-Cardenas G, Anfinson S (1995) Brainstem motoneuron pools that are selectively resistant in amyotrophic lateral sclerosis are referentially enriched in parvalbumin: evidence from monkey brainstem for a calcium-mediated mechanism in sporadic ALS. Exp Neurol 131: 239-250
61. Ripps ME, Huntley GW, Hof PR, Morrison JH, Gordon JW (1995) Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 92: 689-693
62. Rodgers-Johnson P, Garruto RM, Yanagihara R, Chen KM, Gajdusek DC, Gibbs CJ (1986) Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam: a 30-year evaluation of clinical and neuropathological trends. Neurology 36: 7-13
63. Rooke K, Figlewicz DA, Man FY, Rouleau GA (1995) Analysis of the KSP repeat of the neurofilament heavy subunit in familial amyotrophic lateral sclerosis. Ann Neurol 46: 789-790
64. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX, Rachmani Z, Krizus A, McKenna-Yasek D, Cayabyab A, Gaston SM, Berger R, Tanzi RE, Halperin JJ, Herzfeldt B, Bergh RVD, Hung WY, Bird T, Deng G, Mulder DW, Smyth C, Laing NG, Soriano E, Pericak-Vance MA, Haines J, Rouleau GA, Gusella JS, Horvitz HR, Brown RH (1993) Mutation in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59-62
65. Rothstein JD (1996) Excitotoxicity hypothesis. Neurology 47: S19-S26
66. Rothstein JD (1996) Therapeutic horizons for amyotrophic lateral sclerosis. Cur Opin Neurobiol 6: 679-687
67. Rouleau GA, Clark AW, Rooke K, Pramatarova A, Krizus A, Suchowersky O, Julien JP, Figlewicz D (1996) SOD1 mutation is associated with accumulation of neurofilaments in amyotrophic lateral sclerosis. Annals Neurol 39: 128-131
68. Schmidt ML, Carden MJ, Lee VMY, Trojanowski JQ (1987) Phosphate dependent and independent neurofilament epitopes in the axonal swellings of patients with motor neuron disease and controls. Lab Invest 56: 282-294
69. Schmidt ML, Murray JM. Lee VMY, Hill WD. Wertkin A, Trojanowski JQ (1991) Epitope map of neurofilament protein domains on cortical and peripheral nervous system lewy bodies. Am J Pathol 139: 53-65
70. Schmidt ML, Murray JM, Lee VMY, Hill WD, Wertkin A, Trojanowski JQ (1991) Epitope map of neurofilament protein domains on cortical and peripheral nervous system Lewy bodies. Am J Pathol 139: 53-65
71. Shibata N, Hirano A, Kobayashi M, Sasak IS, Kato T, Matsumoto S, Shiozawa Z, Komori T, Kemoto A, Umahara T (1994) Cu/Zn superoxide dismutase-like immunoreactivity in Lewy body-like inclusions of sporadic amyotrophic lateral sclerosis. Neurosci Letters 179: 149-152
72. Smith MA, Rudnicka-Nawrot M, Richey PL, Paprotnick D, Mulvihill P, Miller CA, Sayre L, Perry G (1995) Carbonyl-related post-translational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease. J Neurochem 64: 2660-2666
73. Smith RG, Siklos L, Alexianu ME, Engelhardt JI, Mosier DR, Colom L, Habib Mohamed A, Appel SH (1996) Autoimmunity and ALS. Neurology 47: S40-S45
74. Steinert PM, Roop DR (1988) Molecular and cellular biology of intermediate filaments. Annu Rev Biochem 57: 593-625
75. Terada S, Nakata T, Peterson AC, Hirokawa N (1996) Visualization of slow axonal transport in vivo. Science 273: 784-788
76. Tsuda T, Munthasser S, Fraser PE, Percy ME, Rainero I, Vaula G, Pinessi L, Bergamini L, Vignocchi G, McLachlan DRC, Tatton WG, George-Hyslop PS (1994) Analysis of the funtional effects of a mutation in SOD1 associated with familial amyotrophic lateral sclerosis. Neuron 13: 727-736
77. Tu PH, Gurney ME, Julien JP, Lee VM, Trojanowski JQ (1997) Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease. Lab Investig 76: 441-456
78. Tu PH, Robinson KA, de Snoa F, Eyer J, Peterson A, Lee VM, Trojanowski JQ (1997) Selective degeneration fo Purkinje cells with Lewy body-like inclusions in aged NFHLACZ transgenic mice. J Neurosci 17: 1064-1074
79. Tu PH, Elder G, Lazzarini RA, Nelson D, Trojanowski JQ, Lee VMY (1995) Overexpression of the Human NFM Subunit in Transgenic Mice Modifies the Level of Endogenous NFL and the Phosphorylation State of NFH Subunits. J Cell Biol 129: 1-13
80. Tu PH, Raju P, Robinson KA, Gurney ME, Trojanowski JQ, Lee VMY (1995) Transgenic Mice Carrying a Human Mutant Superoxide Dismutase Transgene Develop Neuronal Cytoskeletal Pathology Resembling Human Amyotrophic Lateral Sclerosis Lesions. Proc Natl Acad Sci USA 93: 3155-3160
81. Vechio JD, Bruijn LI Xu Z, Brown RHJ, Cleveland DW. Vechio JD, Bruijn L, Xu Z, Brown RH, Cleveland DW (1996) Sequence variants in human neurofilament proteins: absence of linkage to familial amyotrophic lateral sclerosis. Ann Neurol 40: 603-610
82. Vickers JC, Morrison JH, Friedrich VL, Elder GA, Perl DP, Katz RN, Lazzarini RA (1994) Age-associated and celltype-specific neurofibrillary pathology in transgenic mice expressing the human midsized neurofilament subunit. J Neuroscience 14: 5603-5612
83. Wiedau-Pazos M, Goto JJ, Rabizadeh S, Gralla EB, Roe JA, Lee MK, Valentine JS, Bredesen DE (1996) Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 271: 515-518
84. Wong PC, Marszalek J, Crawford TO, Xu Z, Hsieh ST, Griffin JW, Cleveland DW (1995) Increasing neurofilament subunit NF-M expression reduces axonal NF-H, inhibits radial growth, and resuits in neurofilamentous accumulation in motor neurons. J Cell Biol 130: 1413-1422
85. Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, Jemkins NA, Sisodia SS, Cleveland DW, Price DL (1995) An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14: 1105-1116
86. Xu Z, Cork LC, Griffin JW, Cleveland DW (1993) Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell 73: 23-33
87. Yamasaki H, Itakura C, Mizutani M (1991) Hereditary hypotrophic axonopathy with neurofilament deficiency in a mutant strain of the Japanese quail. Acta Neuropathol 82: 427-434
88. Zhu Q, Couillard-Després S, Julien JP (1997) Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments. Exp Neurol 148: 299-316